THE E|D|C TEAM

Damien Wilpitz

Founder | Principal Consultant
Damien Wilpitz has served as a scientific research manager for over 15 years and has supported some of the most prestigious institutions; Harvard Medical School, Stanford Medical School, Salk Biological Institute, Scripps Institute, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Institute, Broad Institute and many more. He is now the founder and lead consultant for Experimental Designs Consulting, Inc. The firm consults research investigators on the procedures and the organization of academic research management.

Nicholas Guay-Ross

Academic Relations Consultant

With over 10 years of management experience, Nick has assisted in the resolution of various types of conflict and worked to establish multiple partnerships between researchers, labs, and companies.

Now, as part of the EDC group, he seeks to help solve the core management issues facing scientific institutions, from their faculty, down to their respective research support. By transforming the individual investigator into an efficient team leader we can continue fostering scientific curiosity and successfully realize the dream of discovery.

Brennan McMullen

Life Sciences Research Analyst

Brennan McMullen received his undergraduate degree in Information Systems and Health Sector Management from the Boston University. Originally from Texas, he was drawn to the complexities and magnanimity of healthcare at Boston’s core. As a Dean’s Fellow in both Social Impact and Health & Life Sciences, Brennan began directing his attention towards the trials of academic researchers. For the last 3 years, Brennan has worked with E|D|C to investigate and develop solutions that aid today’s life science leaders. His work derives largely from automating processes and building data software that better help researchers make decisions. He continues to pursue greater security for researchers through improved fund management systems and lab team building.

Jonathan Thon, Ph.D.

Biotech Research Advisor
Platelet BioGenesis is a Harvard University spinout that is making human platelets from stem cells. They have developed and patented a microfluidic bioreactor, and shown that functional platelets can be generated from human pluripotent stem cell cultures. By removing the volunteer donor, Dr. Thon and his team can make platelets that are cheaper, safer, and available on demand.
Prior to founding Platelet BioGenesis, Jonathan was an Assistant Professor at Brigham and Women’s Hospital and Harvard Medical School, where he retains an academic affiliation. His research focuses on developing bio-mimetic microfluidic platforms for cell culture and functional platelet production.
During his postdoctoral fellowship at
Brigham and Womens Hospital and
Harvard Medical School, Thon studied
how specialized cells in the bone marrow
called megakaryocytes produce platelets, a long focus of his mentor Joseph Italiano, a faculty at Harvard Medical School.

ELIZABETH KWO, MD, MBA

Business Management Advisor
Dr. Liz Kwo is an M.D., M.B.A. graduate from Harvard Medical School and Harvard Business School. She received her BA from Stanford University in 2004 and continued onto a Fulbright Scholarship researching elderly health care in Taiwan. She has worked in several companies involved in medical device, technology, and healthcare including companies such as Medtronic and American Well. She currently is the President of New Pathway Education and Technology Group.

BENJAMIN EBERT, MD, PH.D.

Academic Research Advisor
Benjamin Ebert is the Nicola David-Pinedo Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at the Dana-Farber Cancer Institute, and an Institute Member of the Broad Institute.

Dr. Ebert is an elected member of the American Society for Clinical Investigation and the Association of American Physicians, and he served as President of the American Society for Clinical Investigation. His awards include the Till and McCollough Award from the International Society of Experimental Hematopoiesis, the William Dameshek Prize from the American Society of Hematology, and mentoring and teaching awards from Harvard Medical School. He serves on the medical or scientific advisory boards of the Evans Foundation, Babich Foundation, MDS Foundation, the Aplastic Anemia and MDS Foundation, and the Stem Cell Institute at Cambridge University.

Dr. Ebert received a bachelor’s degree from Williams College, a doctorate from Oxford University as a Rhodes Scholar, and an M.D. from Harvard Medical School. He completed a residency in internal medicine at Massachusetts General Hospital and a fellowship in hematology/oncology at the Dana-Farber Cancer Institute. He was on the faculty of Brigham and Women’s Hospital for 10 years before returning to the Dana-Farber.

What are you waiting for?